Retatrutide 20mg
$210.00 inc. GST
Research-grade≥99% purity verifiedFast dispatch
Retatrutide (LY3437943) is a next-generation tri-agonist research peptide targeting the GLP-1, GIP and glucagon receptors.
It is widely studied in metabolic research for its role in appetite regulation, energy expenditure, glucose metabolism and body composition. Each vial contains 10mg of research-grade lyophilised Retatrutide, independently tested in Australia for purity using HPLC and mass spectrometry before dispatch.
1
Fast Australian shipping
Discreet packaging
Australian Tested
- Metabolic Research
- Body Composition
- Appetite Regulation
- Energy Expenditure
- Comparative Research
- 20mg per vial
- Lyophilised powder
- ≥99% purity (HPLC verified)
- Independently tested in Australia
- Phase 3 investigational compound
For laboratory research use only. Not for human consumption.
